Immune Checkpoint Inhibitor-Induced Pneumonitis in Non-Small Cell Lung Cancer: A Narrative Review of Incidence and Clinical Risk Factors.

Simple Summary: Immunotherapy has become part of the main treatment for non-small cell lung cancer. However, it pertains with immunotherapy-related inflammation of the lungs, an uncommon but potentially life-threatening side effect. Identification of patients at risk, early detection, and treatment...

Full description

Bibliographic Details

Published in:	Current Oncology Vol. 33; no. 5; pp. 240 - 256
Main Authors:	Aseyev, Olexiy, Zrielykh, Liliia, Shi, Minghan, Filipovic, Katherine, Seymour, Claire, Siddiqui, Rabail, Biman, Birubi
Format:	Journal Article
Published:	MDPI May2026
Online Access:	View this record in EBSCOhost